Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority to CU20110026ApriorityCriticalpatent/CU20110026A7/en
Publication of CU20110026A7publicationCriticalpatent/CU20110026A7/en
La presente invención se refiere a un compuesto de la fórmula (I); o sales farmacéuticamente aceptables del mismo útiles para el tratamiento de enfermedades proliferativas, tales como cáncer, en mamíferos. ESPACIO PARA LA FÓRMULAThe present invention relates to a compound of the formula (I); or pharmaceutically acceptable salts thereof useful for the treatment of proliferative diseases, such as cancer, in mammals. FORMULA SPACE
CU20110026A2011-02-022011-02-02
SMAC PEPTIDOMYMETICS USEFUL AS INHIBITORS OF APOPTOSIS PROTEINS (IAP)
CU20110026A7
(en)